The issue relates to a patent dispute between American pharmaceutical company Pfizer and Indian pharma major Cipla over the drug Vyndamax
The issue relates to a patent dispute between American pharmaceutical company Pfizer and Indian pharma major Cipla over the drug Vyndamax